Research programme: BACE1 protein inhibitors - PfizerAlternative Names: WAC-547415; WAY-258131; WY-24454
Latest Information Update: 03 Sep 2010
At a glance
- Originator Wyeth
- Developer Pfizer
- Class Fluorobenzenes; Hydantoins; Imidazoles; Pyridines; Small molecules
- Mechanism of Action BACE1 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Alzheimer's disease